Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.

We Liked it at $3.50, we Love it at $2.25. Down but not out. Now trading below the...

Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds Appeal for Both...

Press Release: February 28, 2023 07:30 ET | Source: Society Pass Incorporated New York,...

New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under $5.00.

Our #1 Internet Company Trading Under $5.00, Society Pass Holds Appeal for Both Traders and Long-Term Investors.

Dennis Nguyen, Founder/Chairman/CEO of Nasdaq-listed Society Pass Inc. (Nasdaq: SOPA) to Speak at NXT...

SINGAPORE, Feb. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Society Pass Incorporated ("SoPa”) ( Nasdaq: SOPA ), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce...

Adding Principal Solar (PSWW) to Watch List.

LIVE QUOTE Principal Solar Website

Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.

Two News Reports Related to Revives Upcoming Microneedle Patch Technology While we are still laser focused on Revive...
Silo Pharma, Psychedelic Stock Review, Roland Rick Perry

SILO Pharma (SILO) Gains 53%

For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun. Silo Pharma Gains 53%...

Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.

If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term,...

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...

Initiating Coverage on Society Pass (SOPA).

Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley

Latest article

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Principal Solar, Inc.Mon, March 20, 2023 at 7:30 AM EDT Institutional Analyst, Inc....

Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.

Going Short the Market. No Long Dissertation, No Rush. Market Risk Has Appeared, With Minimal Upside, So Time To Act.

We’re Bearish, but we’re up 257% in Provention Bio (PRVB) Today.

And up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of...